EDITORIAL SECTION

Articles

Revolutionizing Healthcare with Innovative Therapeutics

Revolutionizing healthcare with innovative therapeutics involves the development and application of groundbreaking treatments and approaches that significantly improve patient outcomes reduce costs and enhance overall healthcare effectiveness

Partnership & Collaboration: The Strategic Force Shaping the Future of Pharmaceutical Growth

The pharmaceutical industry is being reshaped by a simple but powerful reality no company however large or capable can build every capability alone The sector is operating in an environment defined

Generative AI in Pharma: Scaling Productivity without Compromising

Most enterprise technologies enter a pharmaceutical company through a single door A manufacturing execution system arrives at a site A clinical data platform arrives in development Governance follows the deployment because there is a deployment to govern Generative AI did not behave this way It reached medical writers regulatory managers safety officers market access teams and commercial staff sim...

Regulatory Challenges in Clinical Testing for New Pharmaceuticals

The clinical testing is a stage where the new pharmaceutical products are a trial on human beings or patients The aims of clinical trials are to assess the effectivenesssafetytolerability or intolerance of new drug in man Generally clinical trials are conducted in phases each phase has different questions regarding the drug

Genetic Testing in Mainstream Medicine: Driving Precision, Prevention, and Population Health

Healthcare systems globally are shifting toward valuebased care where reimbursement is tied to outcomes not procedures Genetic testingparticularly multigene panels and polygenic risk scores is emerging as a highimpact enabler of early intervention and targeted prevention reducing longterm costs and improving clinical outcomes

Navigating European Pharma Regulations: A B2B Perspective

The pharmaceutical industry in the European region practices one of the most regulating laws in the entire world Therefore regulations encompassing these areas are of prime importance for BB companies that need to achieve market entry and maintain compliance Thus this guide is meant to decompartmentalize the array of European pharma regulations and create

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys